Max Healthcare slips 20% in 3 weeks, stock hits over 2-year low; here's why
Max Healthcare share price: In the past three days, the stock price of the hospital company slipped 7% on reports that the government plans to extend the 30% price caps to non-scheduled cancer drugs.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.business-standard.com — the content belongs to Business Standard.
